Qube Research & Technologies (QRT)
NBSE

Qube Research & Technologies (QRT)’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-610
Closed -$87K – 2061
2020
Q1 		$87K Hold
610
– – ﹤0.01% 981
2019
Q4 		$88K Buy
+610
New +$71.5K ﹤0.01% 1457

Other funds holding NBSE

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NBSE Position: Q2 2020 in Review

Qube Research & Technologies (QRT) sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2020, closing a stake of 610 shares — an estimated $87K sold.

Qube Research & Technologies (QRT) first reported a position in NBSE in Q4 2019 and held it in 2 quarters. The position peaked at $88K in Q4 2019. 49 funds tracked by Wall St. Rank hold NBSE as of Q2 2020.

  • Qube Research & Technologies (QRT) reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 610 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $87K.
  • Qube Research & Technologies (QRT) first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s NeuBase Therapeutics, Inc. Common Stock position peaked at $88K in Q4 2019.
  • 49 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2020, filed 14 Aug 2020.